PDRX - PD-Rx Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.72M
Enterprise Value 38.14M
Trailing P/E 15.00
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.36
Price/Book (mrq)0.69
Enterprise Value/Revenue 30.38
Enterprise Value/EBITDA 68.71

Trading Information

Stock Price History

Beta (3Y Monthly) -0.32
52-Week Change 3-28.00%
S&P500 52-Week Change 39.10%
52 Week High 37.5000
52 Week Low 33.9300
50-Day Moving Average 34.3057
200-Day Moving Average 34.4488

Share Statistics

Avg Vol (3 month) 3334
Avg Vol (10 day) 314
Shares Outstanding 51.72M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.66
Forward Annual Dividend Yield 411.00%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Dec 12, 2018
Ex-Dividend Date 4Dec 13, 2018
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2016
Most Recent Quarter (mrq)Dec 31, 1999

Profitability

Profit Margin 2.36%
Operating Margin (ttm)3.55%

Management Effectiveness

Return on Assets (ttm)3.78%
Return on Equity (ttm)4.63%

Income Statement

Revenue (ttm)21.47M
Revenue Per Share (ttm)12.69
Quarterly Revenue Growth (yoy)-2.50%
Gross Profit (ttm)7.57M
EBITDA 934.26k
Net Income Avi to Common (ttm)507.67k
Diluted EPS (ttm)0.3000
Quarterly Earnings Growth (yoy)6.60%

Balance Sheet

Total Cash (mrq)104.55k
Total Cash Per Share (mrq)0.06
Total Debt (mrq)466.84k
Total Debt/Equity (mrq)31.31
Current Ratio (mrq)6.24
Book Value Per Share (mrq)6.53

Cash Flow Statement

Operating Cash Flow (ttm)1.86M
Levered Free Cash Flow (ttm)1.73M